Literature DB >> 4356121

Aspartylglycosaminuria (AGU). Further aspects on its clinical picture, mode of inheritance and epidemiology based on a series of 57 patients.

S Autio, J K Visakorpi, H Järvinen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4356121

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN： 0003-4762


× No keyword cloud information.
  7 in total

1.  Selection in favor of lysosomal storage disorders?

Authors:  J Zlotogora; M Zeigler; G Bach
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

2.  The T99K variant of glycosylasparaginase shows a new structural mechanism of the genetic disease aspartylglucosaminuria.

Authors:  Suchita Pande; Hwai-Chen Guo
Journal:  Protein Sci       Date:  2019-04-09       Impact factor: 6.725

3.  Aspartylglucosaminuria among Palestinian Arabs.

Authors:  J Zlotogora; Z Ben-Neriah; B Y Abu-Libdeh; V Sury; M Zeigler
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

Review 4.  Aspartylglycosaminuria: an inborn error of glycoprotein catabolism.

Authors:  C P Maury
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

5.  Characterization of three alleles causing aspartylglycosaminuria: two from a British family and one from an American patient.

Authors:  H Park; M B Vettese; A H Fensom; K J Fisher; N N Aronson
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

6.  Expression and endocytosis of lysosomal aspartylglucosaminidase in mouse primary neurons.

Authors:  A Kyttälä; O Heinonen; L Peltonen; A Jalanko
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

7.  Functional Analysis of the Ser149/Thr149 Variants of Human Aspartylglucosaminidase and Optimization of the Coding Sequence for Protein Production.

Authors:  Antje Banning; Jan F König; Steven J Gray; Ritva Tikkanen
Journal:  Int J Mol Sci       Date:  2017-03-26       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.